ULTRASOUND PHYSIOTHERAPY TREATMENT OF PROSTATITIS


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Purpose of the study. Develop a method of treatment of prostatitis based on the use of a standard antibiotic, immunomodulatory therapy, and transrectal ultrasound physiotherapy. Materials and methods. The dynamics of the accumulation of the antibiotic was investigated in male rats. Sonication was performed immediately before the administration of the antibiotic and its accumulation in the process at 10, 20, 40, 60, 80, 100 min after dosing. The clinical study included 138 patients with chronic prostatitis. Patients of the experimental group, in addition to standard therapy, 10 sessions of transrectal ultrasound physical therapy was performed. The efficacy of treatment was assessed after 14 and 28 days after initiation. Results and its discussion. Experiments on laboratory animals have shown that the highest concentration and the residence time of antibiotic in the prostate tissue is noted ultrasonic treatment in the period of maximum blood concentration of the test drug. The data obtained allow to determine that the ultrasonic treatment must be performed considering the pharmacokinetics of the antibiotic. In conducting clinical trials on day 14 of treatment and clinical manifestations of prostatitis bacterial microflora in prostatic secretions were no patients in both groups. In 15% of patients of the experimental group the number of leukocytes decreased to the normal range. After 28 days the amount of leukocytes was normal in 51% of patients in the control and 85% in the experimental group. Conclusion. In animal experiments defined the optimal time interval separating the moment of injection of the antibiotic from the beginning of sonication. Clinical studies have shown that the transrectal ultrasound exposure during the period of maximum concentration of the antibiotic in the blood, improves patient outcomes by 33.8%.

Full Text

Restricted Access

About the authors

P. I Talberg

Peoples’ Friendship University of Russia

Email: talberg2006@rambler.ru
graduate student of the Department of Urology and operative Nephrology with the course of oncourology Moscow

M. I Andryukhin

Peoples’ Friendship University of Russia

Email: valeriya-andrew@mail.ru
Moscow

S. E Mazina

Lomonosov Moscow State University

Email: conophytum@mail.ru
Moscow

A. L Nikolaev

Lomonosov Moscow State University

Email: nicmsu@gmail.com
Moscow

References

  1. Bajpayee, P., Kumar K., Sharma S., Maurya N., Kumar P., Singh R., Lal C. Prostatitis: prevalence, health impact and quality improvement strategies. Acta Poloniae Pharmaceutica с Drug Research. 2012;69(4):571-579
  2. Wagenlehner F.M., Pilatz A., Bschleipfer T., Diemer T., Linn T., Meinhardt A., Schagdarsurengin U., Dansranjavin T., Schuppe H.C., Weidner W. Bacterial prostatitis. World J Urol. 2013;31(4):711-716
  3. Доста Н.И., Севостьянов Н.С. Простатит: Современные аспекты этиопатогенеза, диагностики и лечения. Рецепт. 2014;93(1):124-130
  4. Перепанова Т.С., Козлов Р.С., Руднов В.А., Синякова Л.А. Антимикробная терапия и профилактика инфекций почек, мочевыводящих путей и мужских половых органов. Федеральные клинические рекомендации. М., 2015. 72 с
  5. Oldfield E., Feng X. Resistance-resistant antibiotics. Trends in Pharmacological Sciences. 2014;35(12):664-674
  6. Авдошин В.П., Андрюхин М.И., Михайликов Т.Г. Магнитолазерная терапия в комплексе с антисклеротической в лечении больных с хроническим простатитом. Лазерная медицина. 2011;15(2):83-84
  7. Маннапова Г.Ф., Дарий Е.В. Физические факторы в лечении хронического абактериального простатита (синдрома хронической тазовой боли). Урология. 2012;3:74-78
  8. Николаев А.Л., Гопин А.В., Божевольнов В.Е., Андронова Н.В., Трещалина Е.М., Голубева И.С., Дежкунов Н.В. Концепция использования локального ультразвукового воздействия средней интенсивности в онкологии. Сборник трудов научной конференции «Сессия Научного совета РАН по акустике и XXV сессия Российского акустического общества». М.: ГЕОС. 2012;3:60-63
  9. Shriki J. Ultrasound Physics. Critical Care Clinics. 2014;30(1):1-24.
  10. Serpe L. Nanosonotechnology: the next challenge in cancer sonodynamic therapy. Nanotechnol Rev. 2012;1:173-182.
  11. Пономаренко Г.Н. Физиотерапия: национальное руководство. М.: Гэотар-Медиа. 2014. 864 с
  12. Арсланов М.М., Камалов И.И., Фаттахов В.В. Физиотерапевтические методы лечения хронического простатита. Практическая медицина. 2011; 1:22-24
  13. Бойченко А.Н. Применение ультрафонофореза лекарственных средств в комплексной терапии больных хроническим простатитом. Курортная медицина. 2012;3:38-41
  14. Krishna C.A., Vignesh R., Chelladurai R., Patil R.S. A highly specific, sensitive and high throughput method for the determination of ofloxacin in human plasma by liquid chromatography coupled with tandem mass spectrometry. Asian J Pharm Clin Res. 2012;5(3): 174-179
  15. Хоулт Дж., Криг Н., Снит П., Стейл Дж., Уилльямс С. Определитель бактерий Берджи. В 2 т. М.: Мир. 1997; 1:432 с; 2:368 с
  16. Мазина С.Е., Гопин А.В., Николаев А.Л., Тальберг П.И. Соносенсибилизирующее действие терафтала в бактериальных средах. Биофизика. 2015;60(3):525-529

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2016 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies